Dr. Charlotte A. Gaydos is a Professor in the Division of Infectious Diseases, Department of Medicine of the Johns Hopkins University School of Medicine and has joint appointments in the Emergency Medicine Department and Epidemiology at the Johns Hopkins Bloomberg School of Public Health, and is a member of the Johns Hopkins University Center for Global Health. She received her B.S. in medical technology and her M.S. in medical microbiology from West Virginia University. Her MPH and DrPH in Immunology and Infectious Diseases were received from Johns Hopkins University School of Public Health. Dr. Gaydos is the Director of the Johns Hopkins University International STI, Respiratory Diseases, and Biothreat Research Laboratory. She has 50 years laboratory expertise in microbiology, has authored 29 book chapters, over 500 research articles, and over 700 abstracts and oral presentations.
Dr. Gaydos has conducted multiple FDA clinical trials for new diagnostics for STIs and respiratory pathogens. She has extensive laboratory experience in the development and evaluation of molecular amplification testing techniques for respiratory, urogenital, and biothreat specimens, as well as epidemiology expertise. Dr. Gaydos has performed original research developing DNA amplification tests for Chlamydia trachomatis, C. pneumoniae, C. psittaci, Trichomonas vaginalis, N. gonorrhoeae, Mycoplasma genitalium, and the agents of genital ulcer disease. She performed sentinel STI studies in schools and in male and female military recruits. Her Internet recruitment of at-home, self-collected samples for STI screening has been an effective out-reach program, demonstrating an acceptable method for reaching women and men who may not attend clinics.
Her laboratory is CAP accredited, CLIA certified, State of Maryland licensed laboratory is a Core Diagnostic/Reference Laboratory for international studies of sexually transmitted infections, respiratory diseases, and trachoma. She was a co-investigator for 10 years for the Mid-Atlantic Regional Center of Excellence (MARCE) for emerging infectious diseases. She is the Co-Principal Investigator of this NIH/NIBIB Center U54 grant to develop point-of-care tests (POC) for STIs, a Co-PI for the NIH funded R-01 to develop a POC for gonorrhea with detection of antibiotic resistance. She also serves as a co-investigator for the NIH Center of Excellence in Influenza Research and Surveillance (CEIRS).
Dr. Gaydos is the President of the International Union Against Sexually Transmitted Infections (IUSTI). She serves on the editorial boards of the Sexually Transmitted Diseases journal, the Journal of Clinical Microbiology and Sexual Health.